Determining Infectiousness of TB Patients

Similar documents
Turning Off the Spigot Reducing Nosocomial Drug Resistant TB. Edward A. Nardell, MD Harvard Medical School/PIH Brigham & Women s Hospital

World TB Day US issues

The Impact of Effective Treatment on TB Transmission FAST: A re-focused, intensified, administrative approach to institutional TB transmission control

Issues in TB Infection Control. Stopping transmission of TB. The Issue: Transmission of TB. TB Infection Control

Application of New Diagnostics and Preventative Treatment in Low and High Burden Settings

TB Program Management San Antonio, Texas November 5-7, 2008

on Infectivity of Air on a Hospital Ward

Transmission of Mycobacterium tuberculosis

Engineering control of infectious disease: modelling ventilation flows and microbes

TB Nurse Case Management San Antonio, Texas March 7 9, TB Infection Control Robert Petrossian March 8, 2012

TB infection control: overview and importance

Preventing TB Transmission in Health Care Facilities. Webinar October 20, Curry International Tuberculosis Center

Overview of Airborne Infections & Introduction to the Course

Tuberculosis Intensive

Tuberculosis Pathogenesis

The Air We Share: Principles and Practices of TB Infection Control

Infectious Diseases Sapience

TB CONTROL IN HEALTHCARE FACILITIES: A PRACTICAL GUIDE FOR PREVENTION

"GUARDING AGAINST TUBERCULOSIS AS A FIRST RESPONDER"

Transmission and Pathogenesis of Tuberculosis. Transmission and Pathogenesis of Tuberculosis. Mycobacteria. Introduction to the pathogen Transmission

Transmission and Pathogenesis of Tuberculosis

"GUARDING AGAINST TUBERCULOSIS IN HEALTHCARE FACILITIES"

Module 3 - TB Infection control incbo

Transmission of DS-TB and MDR-TB. C. Robert Horsburgh, Jr. Boston University School of Public Health

Filtration for the prevention of airborne infectious disease transmission

Improving Tuberculosis Infection Control

TUBERCULOSIS. Pathogenesis and Transmission

CHAPTER 3: DEFINITION OF TERMS

Kan indeklimaet forbedres og risikoen for smittespredning sænkes uden forøget energiforbrug?

Guidelines for TB Infection Control in High-HIV HIV Burden Settings

Tuberculosis What you need to know. James Zoretic M.D., M.P.H. Regions 2 and 3 Director

"GUARDING AGAINST TUBERCULOSIS IN INSTITUTIONAL FACILITIES"

TB Infection Control. Carol Staton, RN, BSN March 17, TB Nurse Case Management March 17 19, 2015 San Antonio, Texas

TB facts & figures Microbiology of TB Transmission of TB Infection control in health care settings Special cases Resistant TB Masks

2018 Tuberculosis Clinical Intensive: Infection Prevention & Control. > No disclosures

Rebecca O. Sanchez, BSN., RN., MPH. has the following disclosures to make:

Protecting Healthcare Workers from TB in Iowa Douglas Hornick, MD September 27, 2011

Fundamentals of Tuberculosis (TB)

TB Transmission, Pathogenesis & Infection Control

TB Infection Control: Fears and Facts Lisa V. Adams, MD Elizabeth A. Talbot, MD Dartmouth Medical School June 2011

Children as Sentinels for Transmission and Policy Response Mercedes Becerra, ScD

TB, BCG and other things. Chris Conlon Infectious Diseases Oxford

TB Intensive San Antonio, Texas December 1-3, 2010

AEROSOL TRANSMISSIBLE DISEASE STANDARD. Riverside County Department of Public Health 2010

TB Intensive San Antonio, Texas

Predictors of drug sensitive tuberculosis treatment outcomes among hospitalised

Minutes required for removal efficiency ACH 99% 99.9% <1 1

Estimation of Environmental Control Measures for Tuberculosis Transmission in Care Facilities for the Elderly

PREVENTION OF TUBERCULOSIS. Dr Amitesh Aggarwal

Infection Control Standard Precautions and Isolation

TB In Detroit 2011* Early TB: Smudge Sign. Who is at risk for exposure to or infection with TB? Who is at risk for TB after exposure or infection?

At the end of this session, participants will be able to:

Understanding and Managing Latent TB Infection Arnold, Missouri October 5, 2010

Ultra Bio-Logics Inc.

H D R I I N D U S S HEALTH-CARE DESIGN RESOURCE. Tuberculosis (TB) what you should know...

WHERE DO WE GO FROM HERE?

Predicting Spatial Distribution of Infection Risk of Airborne Transmission Diseases in a Hospital Ward

Molecular Epidemiology of Tuberculosis. Kathy DeRiemer, PhD, MPH School of Medicine University of California, Davis

TB Epidemiology. Richard E. Chaisson, MD Johns Hopkins University Center for Tuberculosis Research

EFFICACY OF ENVIRONMENTAL MEASURES IN REDUCING POTENTIALLY INFECTIOUS BIOAEROSOLS DURING SPUTUM INDUCTION

Chapter 7 Tuberculosis Infection Control

PRINCIPLES OF TB CONTROL

Standard Precautions & Isolation Precautions. If you have questions about this module, contact the Infection Prevention department at your facility.

Preventing Tuberculosis (TB) Transmission in Ambulatory Surgery Centers. Heidi Behm, RN, MPH TB Controller HIV/STD/TB Program

Tuberculosis 6/7/2018. Objectives. What is Tuberculosis?

Pandemic Flu: Non-pharmaceutical Public Health Interventions. Denise Cardo,, M.D. Director Division of Healthcare Quality Promotion

INTRODUCTION LITERATURE REVIEW

XDR and MDR TB Urgent Research Priorities. Gerald Friedland MD Yale School of Medicine Nelson R Mandela School of Medicine

UvA-DARE (Digital Academic Repository) Tuberculosis case finding in South Africa Claassens, M.M. Link to publication

Primary Care and TB Control Dr Helen Booth Consultant Thoracic Physician, UCLH Clinical Lead, Integrated TB NCL-Service

HVAC filtration and the Wells-Riley approach to assessing risks of infectious airborne diseases

APSR RESPIRATORY UPDATES

Learning Objectives: Case 1 11/12/2015. Tuberculosis: Focus on Transmission and Pathogenesis. TB: Some Important Terms

TB Contact Investigation Basics

Epidemiological Methods in TB

TB and Respiratory Protection

Tuberculosis and Diabetes Mellitus. Lana Kay Tyer, RN MSN WA State Department of Health TB Nurse Consultant

New Entrant Screening and Latent TB Get screened and find out if you have TB infection before you develop TB disease!

결핵노출접촉자감염관리 서울아산병원감염내과 김성한

TUBERCULOSIS IN HEALTHCARE SETTINGS Diana M. Nilsen, MD, FCCP Director of Medical Affairs, Bureau of Tuberculosis Control New York City Department of

TUBERCULOSIS INFECTION CONTROL PLAN

Tuberculosis & Refugees in Philadelphia

INSTRUCTOR S GUIDE VERSION

ENVE 576 Indoor Air Pollution Fall 2017

Etiological Agent: Pulmonary Tuberculosis. Debra Mercer BSN, RN, RRT. Definition

Ascribe disease risk for the management of airborne transmitted disease in horticultural cropping systems

Infection Control in Tanzania

Experiment #1 TARGET Mouse Model Group. Report prepared by Paul Converse, Ph.D. and Eric Nuermberger, M.D. March 1, 2006

Mycobacterium tuberculosis. Lecture (14) Dr.Baha, AL-Amiedi Ph. D.Microbiology

What s New in TB Infection Control?

TB 2015 burden, challenges, response. Dr Mario RAVIGLIONE Director

Diagnostic challenges of active childhood TB in Tanzania. Michala Vaaben Rose, MD, Ph.D Department of Infectious Diseases, Hvidovre

State of the State in TB Control

New NICE guideline updates recommendations for diagnosing latent tuberculosis

THE DRAFT NATIONAL INFECTION PREVENTION AND CONTROL POLICY FOR TB, MDRTB AND XDRTB.

TB Infection Control in Healthcare Settings

TB/HIV prevention. Implementation science and TB prevention

Transcription:

Determining Infectiousness of TB Patients Edward A. Nardell, MD Brigham & Women s Hospital, Division of Global Health Equity Professor of Medicine, Global Health/Social Medicine, Harvard Medical School & Professor of Environmental Health Harvard School of Public Health Partners In Health, Boston, USA

TB Rates over the Last Century Cape Town, New York, and London Driven by transmission

Content Determining TB Infectiousness: Clinical cough, cavitary CXR, smear pos. Mtb strain infectiousness, environment. Public health contact investigation. Concentric circle approach Quantitative air sampling Cannot culture Mtb from ward air Can from artificial aerosols of BCG, e.g. Human to guinea pig transmission CASS cough aerosol sampling Molecular detection of Mtb DNA Viable particle counting. CO2 monitoring rebreathed air fraction

Propagation of Mycobacterium tuberculosis Aerobiology Aerosolization Source strength Organism number viability phenotype Immunization Host resistance Lung impaction disease Pathogenesis Infection & Re-infection

Wells Air Centrifuge, 1931 On Airborne Infection, Study II. Droplets and Droplet Nuclei W. F. Wells*. Am J Hygiene, 1934:20. 611-18. *Instructor, Sanitary Service, HSPH Wells developed his air centrifuge to sample bacteria from air in a New England textile mill. Richard Riley was his student.

Wells/Riley Experimental TB Ward Quantitative air sampling for TB Riley RL, Mills C, Nyka W. Aerial dissemination of tuberculosis a two year study of contagion on a tuberculosis ward. Am J Hyg 1959; 70:185-196. (reprinted as classic Am J Epidemiol 1995; 142:3-14) Riley RL. What nobody needs to know about airborne infection. (How It Really Happened) AJRCCM 2001; 163:7-8.

Wells/Riley Ward Results (Exp 2) 2.6 GPs infected per month strict criteria Relative infectivity of patients*: Susceptible TB 61 Untreated (29 GPs) 100 29 Treated (1 GP) 2 Drug-resistant TB 6 Untreated (14 GPs) 28 11 Treated (6 GPs) 5 *all smear positive patients, relative to the amount of time on the ward

Human to GP results Mtb is airborne Highly variable infectiousness Mtb variability (Beijing, etc) Drug resistance fitness cost? Source strength highly variable q = 1.25 vs 13 vs 60 vs 250 qph Effective treatment stops transmission quickly

The Airborne Infections Research (AIR) Facility Witbank, Mpumalanga Province, SA Dedicated 2005, Rededicated 2015

Airborne Transmission - Interventions Masks on patients Take off Source strength Treatment** drug resistance Aerobiology Environmental stresses: Admin. Controls F-A-S-T Organism number viability Isolation Virulence Dose Temperature and humidity radiation Landing Dilution (ventilation) (Filtration) UVGI** Host Immunization Resp Protection resistance disease Pathogenesis infection Treatment of latent infection

AIR, Experimental Plan Guinea Pig Air Sampling A B Guinea Pig TB RFLP Odd days Even days UVGI or other intervention 3 patient rooms Plus common areas Intervention on/off on alternative days Pt. TB RFLP

Ventilation ducts in patient rooms Paddle Fans Assure Good Air Mixing

Hazard of becoming infected Results UV1 Intervention Control TST-1 0 1 TST-2 0 3 TST-3 0 5 TST-4 0 0 TOTAL 0 9 UV2 TST1 3 17 TST-2 12 30 TST3 0 1 TOTAL 15 48 *p<0.0005 Combined hazard ratio 4.9 (CI.95: 2.8, 8.6) or about 80% effective. Note: Equivalent of adding 24 ACH to the AIR facility wards AJRCCM available on line

Riley study NIOSH study (primary) NIOSH study AIR Facility study (primary) AIR Facility study (practical) New UVGI Dosing Criteria: 30 W (nominal) Per 200 sq ft floor area 30 50 µw/cm 2 avg. UV fluency rate (measured in a horizontal plane at the level of the lamp) 6.3 W total UVGI lamp wattage per cubic meter upper room volume 6 µw/cm 2 avg. UV fluency rate (for the entire room) 15-20 mw total fixture UV output/m 3 room volume (or approx 20 mw/m 3 ) Does not take lamp or fixture efficiency into account Hard to predict in advance No standard measurement method Does not take fixture efficiency into account Requires gonioradiometry of fixtures for input into Visual-UV CAD program (incorporates ray length) Requires Total Fixture UV Output measurement (supplied by manufacturer) Must adjust for avg ray length in a given room

How Effective are Surgical Masks on Patients? Respirators For patients For health care workers

How Effective Are Surgical Masks on Patients? Guinea Pig Gro up Intervent ion TST 0 TST 1 TST 2 TST 3 TST 4 Total 0 1 10 20 5 36 Control 0 4 15 39 11 69 Approx 53% Effective Dharmadhikari AS, et. al. Am J Respir Crit Care Med. 2012 May 15;185(10):1104-9. NIOSH funded

What is Infection?

Stead s Unitary Theory of tuberculosis pathogenesis Hematogenous spread Latent TB Infection

Laboratory exposure 15 30 cfu All animals clearly infected, all die Palanisamy GS. et.al. Tuberculosis (2008). Our GPs were sacrificed at approximately 280 days

TST size in mm TST size in mm Observations from AIR 100 80 60 Pilot Study 40 20 0 TST1 2 3 4 5 1. 53 guinea pigs reverted their skin test back to 0 mm. 2. No guinea pigs that reverted had signs of TB or pathology 20 20 15 15 10 GP 8 10 GP 33 5 5 0 0 4 8 12 18 Timing of TST (weeks) 0 0 4 8 12 18 Timing of TST (weeks) 33 guinea pigs reverted and had another episode of TST reactivity

Nardell & Wallis, AJRCCM 2006:174

Exposure no infection (91, 25%) Tuberculosis, 2011. 91(4): p. 329-38 Exposure infection (271, 75%) Exposure infection reversion (53,15%) Exposure infection reversion - reinfection (33, 9%) Exposure infection (reinfection) disease (54,15%)

GP Evidence of Reinfection 20 20 15 15 10 GP 338 10 GP 251 5 5 0 0 4 8 12 18 0 0 4 8 12 18

Don Smith Alterative Pathway to Cavitary TB Smith DW, et al. Rev Infect Dis 11: S385-S393 (1989) Stead Theory

Hospitals as Drug Resistant TB Factories Half of the 500,000 new MDR cases per year are transmitte Hospitalized drug susceptible TB patients in Tomsk, Siberia are more that 6 times more likely to develop MDR-TB Glemanova, et al, Bull WHO, 2007; 85:703-711. Drug Susceptible TB or No TB at all Drug Resistant or DS TB Health care workers and patients at great risk of infection and death HIV co-infected at greatest risk Gila Kaplan, BMGF, its all about transmission.

Hospitals as Causes of Human Suffering Referring to the Hotel-Dieu in Paris which had a mortality rate of 1 in 4 patients A fragment of space closed on itself, a place of internment of men and disease, its ceremonious but inept architecture multiplying the ills of its interior without preventing their outward diffusion, the hospital is more of a centre of death (foyer de mort) for the cities where it is sited, than a therapeutic agent for the population as a whole Ref: Medicine and Magnificence British Hospital and Asylum Architecture, 1660 1815, by Christine Stevenson, Yale University Press, 2000, page 155

Florence Nightingale 1820-1910 Notes on Hospital Design 1859 Key role of nurses in airborne Infection control research

Building Design and Engineering for Airborne Infection Control (2008-2016) One week courses this summer in Lima, Peru; and Pretoria, South Africa Two-week course Harvard Course, Boston, Aug 1-16, 2016

Butaro District Hospital, Rwanda (PIH, MASS Design Group) Indus Hospital, MDR Clinic Karachi, Pakistan Alert Hospital, MDR Clinic Addis Ababa, Ethiopia

How Do We Know These Building Designs Work or Don t? Hypothesis: Average personal shared air experience by workers in different hospitals reflects building design and use. Personal ambient CO2 monitoring represents the balance between production (40,000 ppm) by occupants, and reduction by ventilation (400 ppm outside) An index of shared air indicator of risk of TB infection if there is an infectious source

Ethiopia: St. Peter s New Building Very large interior space glass!! No ventilation

How do we know these designs work? Current Assessment Tools Smoke tubes Flow meters Vanometers Tracer gases CO 2 decay Generally reflect a moment in time

Concept Avg personal ambient CO 2 over 4 8 hrs reflects avg rebreathed air experience. An index of airborne risk given a source of infection Reflects building ventilation AND its use, especially occupancy. Compare nurses doing the same job in two different hospital settings

Risk of indoor airborne infection transmission estimated from carbon dioxide concentration. Rudnick SN1, Milton DK. Indoor Air. 2003 Sep;13(3):237-45.

Other Hospital Evaluations Planned in South Africa Tygerberg Hospital, Stellenbosch Kimberly Hospital New London Hospital

New Transmission Issues Global warming need for AC Split systems increasingly common no ventilation Windows closed in ambulatory center, Mumbai MDR/XDR surgery how to do it safely Backlog of cases in Peru staff fearful Major concern of Lion Hospital, Ethiopia ORs normally positive pressure Isolation rooms normally negative pressure Role for GUV and PAPRs

Cough Aerosol Sampling Kevin Fennelly, MD TB Patient Each patient performs 2 cough sampling sessions over 2 successive days

Instantaneous Viable Particle Detection System A new potential tool to evaluating air disinfection Particle counter sorts viable and non-viable Not Mtb specific environmental organisms in facilities vs. Mtb under aerosol chamber conditions Instantaneous read out Can be used on occupied ward Detects NADH and riboflavin as viability biomarkers Laser Beam Sample Airflow

Conclusions: Determining TB Infectiousness: Clinical cough, cavitary CXR, smear pos. Mtb strain infectiousness, environment. Public health contact investigation. Concentric circle approach Quantitative air sampling Cannot culture Mtb from ward air Can from artificial aerosols of BCG, e.g. Human to guinea pig transmission CASS cough aerosol sampling Molecular detection of Mtb DNA Viable particle counting. CO2 monitoring rebreathed air fraction